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Abstract: Females with sepsis have a better prognosis than males, while those of both 
genders with cirrhosis have a high mortality. Impaired immunity accompanies liver 
cirrhosis. The potential association between sex and immunologic response of cirrhotic rats 
in sepsis following immunonutrition was investigated. One hundred and forty-three rats 
were randomly divided into groups. Liver cirrhosis was produced by weekly feeding of CCl4 
for 8 weeks. Among them, 24 male and 19 female underwent castration one month before 
studying. The rats were fed with either immune enhancing diet or control diet for five days, 
then sepsis was induced with cecal ligation and two holes puncture. Main outcomes included 
mortality and serum cytokines (IL-1β, 6, and 10). Comparisons were made both within and 
between genders. Cirrhotic non-castrated male rats showed a significant decrease in 
mortality (64.1% vs. 32.1%, p = 0.032) with better survival than control diet following 
immune enhancing diet. Lower mortality of cirrhotic non-castrated female rats was found 
after immune enhancing diet (69.6% vs. 52.1%, p = 0.365). Cirrhotic castrated male rats 
showed a lower mortality (44.4%) following immune enhancing diet, and cirrhotic castrated 
female rats also showed significantly lower mortality and better survival than control diet 
after immune enhancing diet (87.5% vs. 33.3%, p = 0.004). Plasma concentrations of IL-1β 
were higher in non-oophorectomized female rats fed with control diet compared to immune 
enhancing diet. Non-orchidectomized males and non-oophorectomized females exhibited 
similar increases in IL-10 after immune enhancing diet. Our results demonstrated that 
immunonutrition was more beneficial for male than female cirrhotic rats following sepsis. 
Though orchidectomy was not found to be more advantageous for the normal male rats in 
sepsis, immunonutrition seemed to be as important as sex hormone for female rats in sepsis. 
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1. Introduction 
Behind heart disease and cancer, cirrhosis is the third most common cause of death among people 
aged 45 to 65 years. Almost 2% of the western population has cirrhosis. Many people with mild cirrhosis 
usually have no symptoms and appear to be well for years. Such cases are usually discovered during 
routine tests for other problems or during surgery. But, if patients have moderate to severe cirrhosis of 
the liver, they do not possess enough healthy liver tissue to perform the metabolic and detoxification 
processes that keep the body healthy, especially at times of stress or sepsis [1,2]. 
Gender differences have been reported following trauma and sepsis; female patients have a better 
outcome than males, which may relate to increased levels of anti-inflammatory cytokines [3–8]. Several 
studies [9–11] have demonstrated gender differences in susceptibility to septic challenge. In female mice, 
following cecal ligation and puncture (CLP), improved cell-mediated immune response resulted in a 
significantly improved ability to tolerate sepsis than males [11]. Sex steroids may contribute to the  
above observations regarding sexual dimorphism, and androgens have been found to react 
immunosuppressively [12–17]. Sexual dimorphism may be influenced by the effects of sex hormones 
and a different ratio of pro-inflammatory and anti-inflammatory cytokines in women compared to 
men [7]. Enhanced immune response in females may result from the absence of androgenic hormones in 
females or the immunostimulating effects of female sex steroids [18].  
Based on the previous animal experimental and clinical studies, a clear association between sexual 
dimorphism and various immune functions has been proposed [11,12]. Modulation of the hormonal 
response to immunonutrition [12] has been demonstrated to be effective in septic complication in animal 
studies. We reported that immunonutrition was more important for male rats than female rats during 
sepsis in our previous study [11]. However, data are not yet available on the cirrhotic changes of the liver 
in the animal and the clinical relevance of sex-specific phenomena for immunomodulational changes after 
feeding septic animals or patients with immune enhancing diet. Therefore, this study attempts to assess 
and compare the potential association between sex and immunologic response in cirrhotic rats in sepsis 
following immunonutrition.  
2. Materials and Methods 
2.1. Animal Study  
One hundred and sixty-nine Sprague-Dawley rats weighing 150–200 g were used in the study, 
including 89 males and 80 females. All animals received humane care and the study protocols were 
compliant with the guidelines of Chang Gung Memorial Hospital. The animals were fed in cages for at 
least for five days before the experiment, and diseased rats with body weight loss were excluded. All 
animals were fasted overnight with free access to water before the study.  Nutrients 2012, 4 
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2.2. Production of Liver Cirrhosis 
Liver cirrhosis was produced with weekly feeding of carbon tetrachloride (CCl4) in drinking water 
for 2 months. The rats were then used for further studying. 
2.3. Estrous Phase of Female Rat Was Proven  
Female rats underwent vaginal smear examinations to determine the stage of the estrous cycle. The day 
of estrous was characterized by large clumps of cornified cells. Female rats were chosen based on their 
estrous phase, determined by vaginal smear examination: Low levels of circulating female hormones 
were chosen at the beginning of diet feeding, rising to high levels at the end [19]. 
2.4. Grouping and Studying Procedures 
All 102 rats were divided as follows. Fifty-six cirrhotic males were divided into (1) Immune 
enhancing group (n = 28), fed with an immune enhancing diet (Nu-immune, Nutritec-Enjoy Nutrition 
Center, Taipei, Taiwan) for five days, then sepsis was induced by CLP; (2) Control group (n = 28) was 
fed with control diet for five days, then sepsis was induced by CLP. The other 46 cirrhotic female rats 
were divided into (1) Immune enhancing group (n = 23), fed with immune enhancing diet (Nu-immune) 
for five days, then sepsis was induced by CLP; (2) Control group (n = 23), fed with control diet for 
five days, then sepsis was induced by CLP. 
Another 67 cirrhotic rats, including 33 males and 34 females, were fed in cages for at least five days 
before the experiment. Diseased rats with body weight loss were excluded. All animals were fasted 
overnight with free access to water prior to orchidectomy or oophorectomy. The rats underwent general 
anesthesia with ether before surgery, with male rats receiving bilateral orchidectomy and female rats 
receiving oophorectomy following laparotomy. All rats were returned to their cages after surgery and 
allowed a chow diet for one month. The rats were then divided as follows: 
Thirty-three orchidectomized cirrhotic male rats were divided into (1) An immune enhancing group 
(n = 18), fed with immune enhancing diet (Nu-immune) for five days, and sepsis was induced by CLP; 
(2) A control group (n = 15), fed with control diet for five days, and sepsis was induced by CLP. 
Thirty-four oophorectomized cirrhotic female rats were divided into (1) An immune enhancing group  
(n = 18), fed with immune enhancing diet (Nu-immune) for five days, and sepsis was induced by CLP; 
(2) A control group (n = 16), fed with control diet for five days, and sepsis was induced by CLP. 
The rats received five days with either an: immune enhancing diet (Nu-Immune) feeding, which 
contained 11.1 g of glutamine and 11.6 g of arginine in each 1000 Kcal diet; or a non-immune enhancing 
control diet. The contents of both diets are listed in Table 1. Sepsis then was then induced in the rats 
using CLP.  
The cytokines (IL-1β, 6, and 10) responses were measured using the serum of non-orchidectomized 
male and non-oophorectomized female rats at 0, 2, 4, 8, 12, 16 and 24 h after surgery. Comparisons were 
made both within and between genders.  Nutrients 2012, 4 
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Table 1. Summary of the compositions of immune enhancing diet and control diet. 
  Immune enhancing diet (IED) Control diet 
Protein (% and source)  22% (Whey)  14% (Whey) 
L-Arginine (g/1000 Kcal)  11.6  0 
L-Glutamine (g/1000 Kcal)  11.1  0 
Carbohydrate (% and source)  53% (Maltodextrin, Sucrose) 52%  (Maltodextrin) 
Fat (% and source)  25% (Canola oil and MCT)  34% (Canola oil) 
% Fatty acid polyunsaturated  65.3%  69.1% 
ω-6:ω-3 Fatty acid ratio  3.3:1  3.8:1 
Vitamins & Trace elements    
Vitamin A (mg/100 g)  591  394 
Vitamin B6 (mg/100 g)  1.27  0.75 
Vitamin B12 (μg/100 g)  3.6  2.3 
Vitamin C (mg/100 g)  127  30 
Vitamin E (mg/100 g)  25  15 
Sodium (mg/100 g)  316  263 
Potassium (mg/100 g)  443  575 
Calcium (mg/100 g)  390  275 
Magnesium (mg/100 g)  127  100 
Iron (mg/100 g)  5.9  4.5 
Copper (mg/100 g)  0.6  0.5 
Manganese (mg/100 g)  1.7  1.3 
Zinc (mg/100 g)  7.6  5.6 
Selenium (mg/100 g)  27.0  21.3 
Osmolality (mOsmol/kg)  430 300 
2.5. Induction of Sepsis with CLP Procedure 
Sepsis was induced by CLP procedure as described by Wichterman [20]. The cecum was ligated with 
3-0 silk ligature and two punctures were made with an 18-gauge needle. The cecum was returned to the 
peritoneal cavity and the abdomen closed in two layers. All rats were resuscitated with normal saline 
(4 mL/100 g of body weight) both immediately following and 7 h after surgery. The rats were fasted but 
had free access to water.  
2.6. Assays of Cytokines 
Commercially available ELISA-kits were used to determine interleukin IL-1β, and IL-6 in supernatants 
of whole blood cultures or serum specimens based on the instructions of manufacturer. The assay 
sensitivity, 5 pg/mL IL-10, was measured using a specific enzyme-linked immunosorbent assay, which 
uses the rat anti-human IL-10 monoclonal antibody and a rabbit anti-human IL-10 polyclonal antibody.  
2.7. Statistical Analysis 
The results were presented as mean ± standard error of the mean (SEM). Chi-square analysis was 
used to compare the mortality of rats. One-way analysis of variance and one-way analysis of variance on Nutrients 2012, 4 
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rank were used to determine the significance of the differences between experimental means of changes 
in cytokines. P value less than 0.05 is considered statistically significant.  
3. Results 
The mortalities of non-castrated rats were compared both within and between genders. Table 2 
compares the mortality of cirrhotic male and female rats. CLP mortality decreased from 64.3% to 32.1% 
(p < 0.05) in cirrhotic male rats following feeding with an immune enhancing diet. In comparison, the 
cirrhotic female rats maintained rather similar mortality following feeding with an immune enhancing 
diet (69.6% vs. 52.1%). The mortality induced by CLP in cirrhotic male rats following feeding with 
non-immune enhancing control diet showed no difference to that in the cirrhotic female rats. These results 
demonstrated the important role of immunonutrition for cirrhotic male rats during sepsis. 
Table 2. Comparison of mortality between different diets in cirrhotic male and cirrhotic 
female rats.  
Mortality  Immune enhancing diet (IED)  Control diet  p value 
Cirrhotic male rats after cecal ligation 
and puncture (CLP) 
9/28 (32.1%)  18/28 (64.3%)  0.032 
Cirrhotic female rats after CLP  12/23 (52.1%)  16/23 (69.6%)
  0.365
 
The mortalities of castrated rats were compared both within and between genders. Table 3 compares 
the mortality of cirrhotic castrated male and female rats. The mortality in orchidectomized cirrhotic male 
rats significantly decreased from 86.7% to 44.4% following feeding with an immune enhancing diet. 
The mortality for oophorectomized female rats was also lower after feeding with an immune enhancing 
diet (87.5% vs. 33.3%). These results demonstrated the important role of immunonutrition for both 
cirrhotic castrated male and female rats during sepsis. 
Table 3. Comparison of mortality between different diets in cirrhotic male and female rats 
after castration. 
Mortality  Immune enhancing diet (IED)  Control diet  p value 
Castrated cirrhotic male rats after cecal 
ligation and puncture (CLP) 
8/18 (44.4%)  13/15 (86.7%)  0.032 
Castrated cirrhotic female rats after CLP  6/18 (33.3%)  14/16 (87.5%)  0.004
 
Plasma concentrations of IL-1β  at 0 h  after CLP were too low to be compared among 
non-orchidectomized male rats and non-oophorectomized female rats. Figure 1 displays the changes in 
IL-1β following induction of sepsis among non-orchidectomized male rats and non-oophorectomized 
female rats. The female rats fed with control diet displayed significantly higher IL-1β than the female 
rats fed with immune enhancing diet at 4 h (24 ± 3 μg/mL vs. 12 ± 1 μg/mL), at 12 h (26 ± 4 μg/mL vs. 
15 ± 3 μg/mL), and at 16 h (17 ± 1 μg/mL vs. 6 ± 2 μg/mL) after CLP. However, the male rats with 
immune enhancing diet had higher IL-1β than the rats with control diet at 4 h (20 ± 2 μg/mL vs.  
10 ± 4 μg/mL), but lower levels of IL-1β at 12 h (8 ± 1 μg/mL vs. 15 ± 3 μg/mL) after CLP.  Nutrients 2012, 4 
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Figure 1. Plasma concentrations of IL-1β (μg/mL) in rats at 0, 2, 4, 8, 12, 16, and 24 h after 
CLP in cirrhotic female rats fed with control diet (n = 28), cirrhotic female rats fed with 
immune enhancing diet (n = 28), cirrhotic male rats fed with control diet (n = 23), and 
cirrhotic male rats fed with immune enhancing diet (n = 23). * p < 0.05 between male rats;  
# p < 0.05 between female rats; IL-1β, interleukin-1β. The data are expressed as Mean ± SEM. 
 
Figure 2. Plasma concentrations of IL-β (μg/mL) in rats at 0, 2, 4, 8, 12, 16, and 24 h after 
CLP in cirrhotic female rats fed with control diet (n = 28), cirrhotic female rats fed with 
immune enhancing diet (n = 28), cirrhotic male rats fed control diet (n = 23), and cirrhotic 
male rats fed with immune enhancing diet (n = 23). * p  < 0.05 between male rats;   
# p < 0.05 between female rats; IL-6, interleukin-6. The data are expressed as Mean ± SEM. 
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The changes in IL-6 following induction of sepsis among non-orchidectomized male rats and 
non-oophorectomized female rats are shown in Figure 2. Female rats fed immune enhancing diet had 
significantly lower IL-6 than the rats fed control diet at 4 h (4 ± 1 μg/mL vs. 42 ± 3 μg/mL). Both the 
male and female rats fed immune enhancing diet had significantly lower IL-6 than the rats fed control 
diet at 8 h (male rats: 20 ± 2 μg/mL vs. 30 ± 4 μg/mL; female rats: 2 ± 0 μg/mL vs. 8 ± 2 μg/mL). The 
response of IL-6 between male and female rats following immune enhancing diet feeding was similar, 
and they produced less pro-inflammatory cytokines after immunonutrition. 
The changes in IL-10 following induction of sepsis among non-orchidectomized male rats and 
non-oophorectomized female rats are shown in Figure 3. Both the male and female rats fed immune 
enhancing diet had significantly higher IL-10 than the rats fed control diet at 4 h (male rats:   
23 ± 1 μg/mL vs. 13 ± 3 μg/mL; female rats: 88 ± 10 μg/mL vs. 3 ± 1 μg/mL), and at 8 h (male rats:  
19 ± 3 μg/mL vs. 9 ± 1 μg/mL; female rats: 22 ± 3 μg/mL vs. 6 ± 0 μg/mL).The response of IL-10 
between male and female rats following immune enhancing diet feeding was similar, and they produced 
higher anti-inflammatory cytokines after immunonutrition. 
Figure 3. Plasma concentrations of IL-10 (μg/mL) in rats at 0, 2, 4, 8, 12, 16, and 24 h after 
CLP in cirrhotic female rats fed with control diet (n = 28), cirrhotic female rats fed with 
immune enhancing diet (n = 28), cirrhotic male rats fed with control diet (n = 23), and 
cirrhotic male rats fed with immune enhancing diet (n = 23).
 * p < 0.05 between male rats;  
# p < 0.05 between female rats; IL-10, interleukin-10. The data are expressed as Mean ± SEM. 
 
4. Discussion 
The liver contains a large number of immune cells representing the innate immune system (e.g., NK 
cells, NKT cells, γ/δ T cells and Kupffer cells). These play a key role, not only in the host defenses 
against invading microorganisms and tumor formation, but also in the pathogenesis of various 
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inflammatory liver diseases [1]. Liver fibrosis and the end-stage of liver fibrosis, cirrhosis, represent the 
final common pathway of virtually all kinds of chronic liver diseases [21]. Liver cirrhosis can be 
produced in animals with chronic infusion of CCl4. Chronic intoxication with CCl4 may result in 
hepatocyte damage, necrosis, inflammation and fibrosis. This spreads to link the vascular structures that 
feed into and drain the hepatic sinusoid, and over 8–12 weeks results in the development   
of cirrhosis [22]. 
There is not enough healthy liver tissue in a cirrhotic liver to perform the metabolic and detoxification 
processes that lead to impaired immunity in cirrhotic patients. Immune paralysis, defined as decreased 
HLA-DR expression on monocytes, indicating immune dysfunction, was found in sepsis, severe acute 
pancreatitis and acute liver failure. Child-Pugh class C cirrhotic patients suffer from down-regulation of 
HLA-DR expression. Endotoxemia contributes to this HLA-DR down-regulation [23].
 The natural killer 
cell activity was significantly decreased in cirrhotic patients compared with normal controls and patients 
with chronic active hepatitis. Cirrhotic patients with Pugh’s C grade of severity of liver disease had 
lower natural killer cell activity. The depression of natural killer cell activity in cirrhotic patients was 
inversely correlated with prothrombin time ratios, and the natural killer cell activity in cirrhotic patients 
with hepatic encephalopathy was lower than in patients without hepatic encephalopathy. Thus, the 
diminished natural killer cell activity in cirrhotic patients might be related to the severity of liver 
damage [2]. 
Several specific nutrients, such as arginine, glutamine, ω-3 fatty acids and nucleotides, have been 
demonstrated to enhance immune function in various experimental models and clinical studies [24–26]. 
These nutritional substrates can improve the proliferation and functions of macrophages and 
lymphocytes thus enhancing patient cellular immunity. Arginine is essential in catabolic states in   
adults; it plays a fundamental role in nitrogen metabolism and polyamine synthesis [23,27,28].   
Glutamine is an important energy source for enterocytes and exerts an immunomodulational effect. 
Glutamine-enriched enteral nutrition has been proven to reduce the incidence of sepsis in trauma 
patients [29,30]. Omega-3 fatty acids modulate the production of both lipid (eicosanoids) and protein 
(cytokines) mediators, they interact with the ω-6 fatty acids in a highly complex manner [31–33]. There 
are many studies involved trauma, surgical and critically ill patients. Surgical patients   
with gastrointestinal cancer were analyzed separately. The analysis demonstrated that supplementation 
with immunonutrition was associated with a significantly decreased incidence of infectious 
complications and length of hospital stay in critically ill and postoperative surgical patients   
with GI cancer [34]. 
Our data demonstrated different responses to immune enhancing diet between male and female 
cirrhotic rats. The mortality of cirrhotic male rats with sepsis is roughly the same as that of cirrhotic 
female rats, but decreased significantly after feeding with immune enhancing diet. The male rats thus 
need more aggressive immunomodulation to prevent higher mortality in sepsis than female rats.   
The mortality of cirrhotic female rats did not differ significantly between the two different diets. 
Immunomodulation was also important for both oophorectomized female and orchidectomized male rats. 
More importantly, the female oophorectomized cirrhotic rats thus required the protection of sepsis by 
immune enhancing diet once they lost the protection of their own sex hormones. 
The female rats have the lowest levels of sex hormones during the estrous phase, and the highest 
levels of sex hormones in their pre-estrous phase. The estrous cycle of rats is usually 4 days/cycle [20]. Nutrients 2012, 4 
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As the feeding of our study takes 5 days, and the need for low levels of sex hormones before feeding, we 
chose female rats in a similar estrous phase at the beginning of the study and induced sepsis around their 
diestrous or proestrous phase when the levels of sex hormones will be high. The change of 
pro-inflammatory cytokines, such as IL-1β or IL-6, could explain the different responses of 
non-orchidectomized male and non-oophorectomized female rats following feeding of immune 
enhancing or non-immune enhancing diet. The above data reveal that female cirrhotic rats produce less 
pro-inflammatory cytokine following feeding with an immune enhancing diet, but the male rats did not. 
The response of IL-10 was similar in both male and female rats following feeding with an immune 
enhancing diet, which overcomes the higher pro-inflammatory cytokine produced by male rats than 
female rats.  
From our data presented here, both the non-orchidectomized cirrhotic male and non-oophorectomized 
female cirrhotic rats fed with immune enhancing diet displayed significantly higher IL-10 than the rats 
fed with non-immune enhancing diet, reflecting the important effects of the immune enhancing diet. 
Interleukin-10 is known as a potent anti-inflammatory cytokine, which inhibits the production of other 
cytokines from activated macrophages and T-helper cells [34]. Increased production of IL-10 is an 
important regulatory mechanism in controlling cytokine-producing cells [35]. Moreover it is rather 
protective, producing increased survival rates in experimentally induced sepsis [36–38]. Mortality 
reduced significantly in male rats fed with an immune enhancing diet, but the female rats displayed no 
significant change, with mortality remaining low regardless. This phenomenon can be explained by the 
fact that male rats require more aggressive immunostimulation to produce sufficient anti-inflammatory 
cytokines, such as IL-10, to reduce their mortality from sepsis.  
5. Conclusion 
In conclusion, immunonutrition was more beneficial for cirrhotic male rats than female rats following 
sepsis. Though orchidectomy was not found to be more advantageous for the normal male rats in sepsis, 
immunonutrition seemed to be as important as sex hormone for female rats in sepsis.  
Implications 
Our previous publication [9] had a pilot study to show evidence about gender-different responses 
after immunonutrition in sepsis. Now, this study again reveals similar evidence in a cirrhotic condition, 
which will provide more suggestions for the clinical use of immunonutrition. 
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